168 related articles for article (PubMed ID: 25666357)
1. Type 1 reaction in leprosy: a model for a better understanding of tissue immunity under an immunopathological condition.
Andrade PR; Pinheiro RO; Sales AM; Illarramendi X; Barbosa MG; Moraes MO; Jardim MR; Nery JA; Sampaio EP; Sarno EN
Expert Rev Clin Immunol; 2015 Mar; 11(3):391-407. PubMed ID: 25666357
[TBL] [Abstract][Full Text] [Related]
2. Severe type 1 upgrading leprosy reaction in a renal transplant recipient: a paradoxical manifestation associated with deficiency of antigen-specific regulatory T-cells?
Vieira AP; Trindade MAB; de Paula FJ; Sakai-Valente NY; Duarte AJDS; Lemos FBC; Benard G
BMC Infect Dis; 2017 Apr; 17(1):305. PubMed ID: 28438129
[TBL] [Abstract][Full Text] [Related]
3. Autophagy-Associated IL-15 Production Is Involved in the Pathogenesis of Leprosy Type 1 Reaction.
Silva BJA; Bittencourt TL; Leal-Calvo T; Mendes MA; Prata RBDS; Barbosa MGM; Andrade PR; Côrte-Real S; Sperandio da Silva GM; Moraes MO; Sarno EN; Pinheiro RO
Cells; 2021 Aug; 10(9):. PubMed ID: 34571865
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal immune responses and gene expression profiles in type 1 leprosy reactions.
Geluk A; van Meijgaarden KE; Wilson L; Bobosha K; van der Ploeg-van Schip JJ; van den Eeden SJ; Quinten E; Dijkman K; Franken KL; Haisma EM; Haks MC; van Hees CL; Ottenhoff TH
J Clin Immunol; 2014 Feb; 34(2):245-55. PubMed ID: 24370984
[TBL] [Abstract][Full Text] [Related]
5. Leprosy and its reactional episodes: Serum levels and possible roles of omega-3 and omega-6-derived lipid mediators.
de Macedo CS; de Carvalho FM; Amaral JJ; de Mendonça Ochs S; Assis EF; Sarno EN; Bozza PT; Pessolani MCV
Cytokine; 2018 Dec; 112():87-94. PubMed ID: 30017389
[TBL] [Abstract][Full Text] [Related]
6. Changes in the size and number of skin lesions in PB leprosy on treatment and follow-up.
Rao PN; Suneetha S; Pratap DV
Lepr Rev; 2011 Sep; 82(3):244-52. PubMed ID: 22125932
[TBL] [Abstract][Full Text] [Related]
7. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
[TBL] [Abstract][Full Text] [Related]
8. Gene set signature of reversal reaction type I in leprosy patients.
Orlova M; Cobat A; Huong NT; Ba NN; Van Thuc N; Spencer J; Nédélec Y; Barreiro L; Thai VH; Abel L; Alcaïs A; Schurr E
PLoS Genet; 2013; 9(7):e1003624. PubMed ID: 23874223
[TBL] [Abstract][Full Text] [Related]
9. [Diagnosis and treatment of leprous neuropathy in practice].
Flageul B
Rev Neurol (Paris); 2012 Dec; 168(12):960-6. PubMed ID: 23131313
[TBL] [Abstract][Full Text] [Related]
10. Understanding the type 1 reactional state for early diagnosis and treatment: a way to avoid disability in leprosy.
Nery JA; Bernardes Filho F; Quintanilha J; Machado AM; Oliveira Sde S; Sales AM
An Bras Dermatol; 2013; 88(5):787-92. PubMed ID: 24173185
[TBL] [Abstract][Full Text] [Related]
11. [Anti-leprosy vaccines and drugs].
Abe M
Nihon Rai Gakkai Zasshi; 1994 Mar; 63(1):1-2. PubMed ID: 7928797
[No Abstract] [Full Text] [Related]
12. BCG vaccination in leprosy.
Price JE
Int J Lepr Other Mycobact Dis; 1982 Jun; 50(2):205-12. PubMed ID: 6749707
[No Abstract] [Full Text] [Related]
13. Differential interferon- gamma production characterizes the cytokine responses to Leishmania and Mycobacterium leprae antigens in concomitant mucocutaneous leishmaniasis and lepromatous leprosy.
Matos DS; Azeredo-Coutinho RB; Schubach A; Conceição-Silva F; Baptista C; Moreira JS; Mendonça SC
Clin Infect Dis; 2005 Jan; 40(2):e5-12. PubMed ID: 15655736
[TBL] [Abstract][Full Text] [Related]
14. [Diagnosis and treatment of leprosy].
López-Antuñano FJ
Salud Publica Mex; 1998; 40(1):66-75. PubMed ID: 9580503
[No Abstract] [Full Text] [Related]
15. High levels of inflammatory cytokines are associated with poor clinical response to steroid treatment and recurrent episodes of type 1 reactions in leprosy.
Manandhar R; Shrestha N; Butlin CR; Roche PW
Clin Exp Immunol; 2002 May; 128(2):333-8. PubMed ID: 11985524
[TBL] [Abstract][Full Text] [Related]
16. Study of cytokine response against panel of purified Mycobacterium leprae antigens by using whole blood assay in subjects residing in a resettlement village of cured leprosy patients.
Kamble RR; Shinde VS; Madhale SP; Jadhav RS
Indian J Lepr; 2010; 82(1):23-31. PubMed ID: 21229844
[TBL] [Abstract][Full Text] [Related]
17. Antigens of Mycobacterium leprae in urine during treatment of patients with lepromatous leprosy.
Olcén P; Harboe M; Warndorff van Diepen T
Lepr Rev; 1986 Dec; 57(4):329-40. PubMed ID: 3540495
[No Abstract] [Full Text] [Related]
18. Mimicking B and T cell epitopes between Mycobacterium leprae and host as predictive biomarkers in type 1 reaction in leprosy.
Pathak VK; Singh I; Singh SV; Sengupta U
Sci Rep; 2021 Dec; 11(1):24431. PubMed ID: 34952925
[TBL] [Abstract][Full Text] [Related]
19. Association of viable Mycobacterium leprae with Type 1 reaction in leprosy.
Save MP; Dighe AR; Natrajan M; Shetty VP
Lepr Rev; 2016 Mar; 87(1):78-92. PubMed ID: 27255061
[TBL] [Abstract][Full Text] [Related]
20. Prospects for chemotherapy of leprosy.
Ji B
Indian J Lepr; 2000; 72(2):187-98. PubMed ID: 11008659
[No Abstract] [Full Text] [Related]
[Next] [New Search]
